InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-60.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the full record of transactions filed by Newell William J, Chairman & CEO. Director active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 14 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €71k. History available since 1 July 2021. The latest transaction was filed on 5 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Newell William J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
18,750 shares0Common StockSEC:0001415889-25-007405:0
31,125 shares0Common StockSEC:0001415889-25-007183:0
23,750 shares0Common StockSEC:0001415889-25-006690:0
18,750 shares0Common StockSEC:0001415889-24-007188:0
31,125 shares0Common StockSEC:0001415889-24-007039:0
23,750 shares0Common StockSEC:0001415889-24-006725:0
13,750 shares0Common StockSEC:0001415889-24-002072:0
31,125 sharesCommon StockSEC:0001209191-23-016809:0
13,750 shares0Common StockSEC:0001209191-23-005765:0
10,000 shares@ US$7.7508100.0% of flowCommon StockSEC:0001209191-22-018969:0
Canonical exit: 12 Jun 2022 (T+90)
18,750 sharesCommon StockSEC:0001209191-22-016856:0
13,750 shares0Common StockSEC:0001209191-22-006128:0
26,091 shares0Common StockSEC:0001209191-22-000329:0
104,662 shares0Common StockSEC:0001209191-21-057981:0
14 of 14 declarations
About Newell William J
NEWELL WILLIAM J is Chairman and Chief Executive Officer and is involved with Sutro Biopharma, INC. (XNAS). Across 14 filings, the 14 sampled filings run from 2021-09-28 to 2025-03-07 and are mainly related to an option exercise, with buy volume of EUR 70900 and no sell amount reported.
